Health Care & Life Sciences » Biotechnology | Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
66.44 M
Public Float
53.91 M
Sarepta Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.94
Market Cap
$11.18 B
Shares Outstanding
74.15 M
Public Float
66.53 M

Profile

Address
215 First Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.sareptatherapeutics.com
Updated 07/08/2019
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases. It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Financials

View All
Created with Highcharts 5.0.14Sarepta Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.111 985111 985135 789135 789220 030220 030267 265267 26550 68850 688361 918361 9182013201420152016201720180100k200k300k400k
Created with Highcharts 5.0.14Sarepta Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.14 21914 2199 7579 7571 2531 2535 4215 421154 584154 584301 034301 034201320142015201620172018050k100k150k200k250k300k350k

Douglas S. Ingram
President, Chief Executive Officer & Director
M. Kathleen Behrens
Chairman